
    
      The primary objective for this study is to compare the proportion of attacks in which pain
      reduction (defined as a decrease in pain intensity of at least 1 point) is achieved at 30
      minutes following 20 mg OPTINOSE SUMATRIPTAN treatment with 100 mg Sumatriptan Tablets
    
  